Risk factors and indices of osteomyelitis of the jaw in osteoporosis patients: results from a hospital-based cohort study in Japan (Q35041287)

6 August 2017

Risk factors and indices of osteomyelitis of the jaw in osteoporosis patients: results from a hospital-based cohort study in Japan (English)

1 reference

6 August 2017

1 reference

10

Kazuhisa Bessho

1 reference

6 August 2017

Toru Yamazaki

1

1 reference

6 August 2017

Masashi Yamori

2

1 reference

6 August 2017

Shiro Tanaka

3

1 reference

6 August 2017

Keiichi Yamamoto

4

1 reference

6 August 2017

Eriko Sumi

5

1 reference

6 August 2017

Megumi Nishimoto-Sano

6

1 reference

6 August 2017

Keita Asai

7

1 reference

6 August 2017

Katsu Takahashi

8

1 reference

6 August 2017

Takeo Nakayama

9

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 November 2013

1 reference

6 August 2017

1 reference

6 August 2017

8

1 reference

6 August 2017

11

1 reference

6 August 2017

e79376

1 reference

Creative Commons Attribution 4.0 International

6 August 2017

start time

1 November 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Report of the committee on the classification and diagnostic criteria of diabetes mellitus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3815193

A pragmatic method for electronic medical record-based observational studies: developing an electronic medical records retrieval system for clinical research

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3815193

Incidence of osteonecrosis of the jaw among users of bisphosphonates with selected cancers or osteoporosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3815193

New approach to analyze genetic and clinical data in bisphosphonate-induced osteonecrosis of the jaw.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3815193

Genomewide pharmacogenetics of bisphosphonate-induced osteonecrosis of the jaw: the role of RBMS3

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3815193

Bisphosphonates for osteoporosis in primary biliary cirrhosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3815193

Risk factors for osteonecrosis of the jaws: a case-control study from the CONDOR dental PBRN

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3815193

ONJ in two dental practice-based research network regions

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3815193

Adverse events and intravenous versus oral bisphosphonate use in patients with osteoporosis and cancer in the U.S.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3815193

Practical guidelines for the prevention, diagnosis, and treatment of osteonecrosis of the jaw in patients with cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3815193

Radiographic findings in bisphosphonate-treated patients with stage 0 disease in the absence of bone exposure

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3815193

Bisphosphonate osteonecrosis of the jaw--a literature review of UK policies versus international policies on bisphosphonates, risk factors and prevention.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3815193

Diabetes in Asia: epidemiology, risk factors, and pathophysiology

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3815193

American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws--2009 update

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3815193

Zoledronate, smoking, and obesity are strong risk factors for osteonecrosis of the jaw: a case-control study

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3815193

Osteonecrosis of the jaw and bisphosphonate treatment for osteoporosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3815193

Use of oral bisphosphonates and the risk of aseptic osteonecrosis: a nested case-control study.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3815193

Bisphosphonates and osteomyelitis of the jaw: a pathogenic puzzle

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3815193

Lack of association between oral bisphosphonates and osteonecrosis using jaw surgery as a surrogate marker

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3815193

Assessing the risk of osteonecrosis of the jaw due to bisphosphonate therapy in the secondary prevention of osteoporotic fractures.

8 July 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0079376

Risk of osteomyelitis of the jaw induced by oral bisphosphonates in patients taking medications for osteoporosis: a hospital-based cohort study in Japan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0079376

Bisphosphonate-induced osteonecrosis of the jaws: prospective study of 80 patients with multiple myeloma and other malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0079376

Nonexposed bisphosphonate-related osteonecrosis of the jaws: another clinical variant?

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0079376

Sinus tracts--an early sign of bisphosphonate-associated osteonecrosis of the jaws?

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0079376

Oral bisphosphonate use increases the risk for inflammatory jaw disease: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0079376

Possible association between diabetes and bisphosphonate-related jaw osteonecrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0079376

Initial experience with conservative treatment in cancer patients with osteonecrosis of the jaw (ONJ) and predictors of outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0079376

Prognostic factors and jaw and renal complications among multiple myeloma patients treated with zoledronic acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0079376

Intravenous bisphosphonate-related osteonecrosis of the jaw: long-term follow-up of 109 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0079376

An aromatase polymorphism (g.132810C>T) predicts risk of bisphosphonate-related osteonecrosis of the jaw.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0079376

Natural History of Osteonecrosis of the Jaw in Patients With Multiple Myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0079376

Bisphosphonate-Associated Osteonecrosis of the Jaw: Report of a Task Force of the American Society for Bone and Mineral Research

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0079376

Osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates: evidence of increased risk after treatment with zoledronic acid

21 January 2018

1 reference

12 December 2020

Clinical comparison of patients with osteonecrosis of the jaws, with and without a history of bisphosphonates administration

1 reference

12 December 2020

Canadian consensus practice guidelines for bisphosphonate associated osteonecrosis of the jaw

1 reference

12 December 2020

Intravenous bisphosphonate therapy and inflammatory conditions or surgery of the jaw: a population-based analysis

1 reference

12 December 2020

Osteonecrosis of the jaw in prostate cancer patients with bone metastases treated with zoledronate: a retrospective analysis

1 reference

12 December 2020

Bisphosphonate-related osteonecrosis of the jaw: position paper from the Allied Task Force Committee of Japanese Society for Bone and Mineral Research, Japan Osteoporosis Society, Japanese Society of Periodontology, Japanese Society for Oral and Max

1 reference

12 December 2020

Leukopenia as a risk factor for osteonecrosis of the jaw in metastatic prostate cancer treated using zoledronic acid and docetaxel

1 reference

12 December 2020

10.1371/JOURNAL.PONE.0079376

Identifiers

DOI

1 reference

6 August 2017

0 references

1 reference

6 August 2017

1 reference